FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

34105011000001109: Ibandronic Acid 150mg tablets (Genesis Pharmaceuticals Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
103442401000001112 Ibandronic Acid 150mg tablets (Genesis Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
103771501000001112 Ibandronic acid 150mg tablets (Genesis Pharmaceuticals Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ibandronic Acid 150mg tablets (Genesis Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ibandronic Acid 150mg tablets (Genesis Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ibandronic Acid 150mg tablets (Genesis Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Ibandronic Acid 150mg tablets (Genesis Pharmaceuticals Ltd) Is a Ibandronic acid 150mg tablets true Inferred relationship Existential restriction modifier
Ibandronic Acid 150mg tablets (Genesis Pharmaceuticals Ltd) Has active ingredient Ibandronic acid true Inferred relationship Existential restriction modifier
Ibandronic Acid 150mg tablets (Genesis Pharmaceuticals Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Ibandronic Acid 150mg tablets (Genesis Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ibandronic Acid 150mg tablets (Genesis Pharmaceuticals Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ibandronic Acid 150mg tablets (Genesis Pharmaceuticals Ltd) Has specific active ingredient Ibandronic sodium monohydrate false Inferred relationship Existential restriction modifier
Ibandronic Acid 150mg tablets (Genesis Pharmaceuticals Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Ibandronic Acid 150mg tablets (Genesis Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ibandronic acid true Inferred relationship Existential restriction modifier
Ibandronic Acid 150mg tablets (Genesis Pharmaceuticals Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Ibandronic Acid 150mg tablets (Genesis Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Ibandronic Acid 150mg tablets (Genesis Pharmaceuticals Ltd) Has basis of strength substance Ibandronic acid true Inferred relationship Existential restriction modifier
Ibandronic Acid 150mg tablets (Genesis Pharmaceuticals Ltd) Has specific active ingredient Ibandronate sodium monohydrate true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Ibandronic Acid 150mg tablets (Genesis Pharmaceuticals Ltd) 1 tablet Has AMP True Ibandronic Acid 150mg tablets (Genesis Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start